INTRODUCTION
Diabetic poly neuropathy, a common complication of diabetes, is diagnosed by symptoms, signs, physical examination, nerve conduction studies, and other neurophysiological methods. Although nerve conduction studies are useful in the diagnosis and evaluation of diabetic neuropathy, there are difficulties in using them for the differential diagnosis of peripheral neuropathy because the pathological changes of diabetic neuropathy are varied. As a result, diabetic neuropathy is diagnosed essentially by excluding various other possible causes of neuropathy. [1] The F-wave is a late muscle response that results from the anti dromic activation of one or a small number of motor neurons following electrical stimulation of a peripheral nerve. [2] Kimura et al. [3] focused on use of the F-wave because it allows assessment of the proximal nerve segment, which is not accessible by the conventional nerve conduction studies. They reported that the F ratio, calculated from the latency of proximal and distal segments of peripheral nerves, was smaller in diabetic patients than in control participants. They suggested that the distal segment is more dominantly damaged in diabetic poly neuropathy. [3] Authors studied the specificity of a new F Wave parameter, the ratio of motor nerve conduction velocity to F-wave conduction velocity (M/F ratio), in diagnosing diabetic neuropathy to the exclusion of other peripheral neuropathies.
MATERIALS AND METHODS

Participants
The study was conducted on 170 Participants in the following groups: 100 patients with clinical or subclinical diabetic neuropathy with diffuse symmetrical peripheral neuropathy (55men, 45 women; mean age 60 ± 10 years), 45 non diabetic patients with peripheral neuropathy (33 men, 12 women; mean age 48 ± 21 years), and 25 normal control Participants (12 men, 13 women; mean age 62 ± 12 years), in King Abdullah Hospital Saudi Arabia, The criteria for the diagnosis of diabetic\ poly neuropathy were at least two abnormalities among clinical symptoms, neurological examinations, electro-diagnostic\ studies, quantitative sensory testing, and autonomic function testing. Patients with subclinical diabetic neuropathy were identified by completing the above criteria, except for clinical symptoms. Patients were excluded if clinical evaluations revealed severe renal complications, carpal tunnel syndrome, nerve root compression, or mononeuropathy. The diabetes group consisted of 75 patients with N1DDM (40 men, 35 women; mean age 63 ± 8 years; HbAlc 8.0 ± 1.9%), and 25 patients with IDDM (14 men, 11 women; mean age 49 ± 10 years; HbAlc 9.4 ± 1.6%). The mean duration of diabetes was 13.9 ± 8.8 years. The 45 patients with non-diabetic peripheral neuropathy were grouped according to the following diagnoses: (1) fifteen patients with segmental demyelination, nine with Guillain-Barre syndrome, five with chronic inflammatory demyelinating poly-radiculo-neuropathy (CIDP), and one with hereditary motor and sensory neuropathy (HMSN), type 1; (2) eleven patients with axonal neuropathy, five with toxic neuropathy, one with vitamin deficiency neuropathy, one with subacute myelo-optico-neuropathy (SMON), two with ischemic neuropathy, and two with amyloid neuropathy; (3) four patients with alcoholic polyneuropathy; and (4) fourteen patients with other poly neuropathy.
Nerve Conduction Study
The protocol for electro diagnosis recommended by the American Diabetes Association was used. [4] MCV of posttibial nerves and SCV of sural nerves were measured. For MCV of the post-tibial nerves, supra maximal stimuli were applied to the ankle and knee, and the compound muscle action potential was recorded from surface electrodes placed over the abductor hallucis muscle. Motor nerve conduction time, which is defined as the difference between the proximal and distal motor nerve latencies, in this instance, gave the motor nerve conduction velocity (MVC) of the knee-to ankle segment of the leg, when divided into the knee-to-ankle distance. For sensory nerve conduction velocity (SCV) of the sural nerves, surface electrodes were placed adjacent to the lateral malleolus of the ankle, and stimulation was applied 13 cm proximal to the active electrode. F responses were recorded from post tibial nerves by use of the same electrode arrangement as for MCV studies, employing shocks of supra maximal intensity to the ankle. A total of 16 F-waves were recorded, and minimal F-wave latency was determined. [5] F-wave conduction velocity (FWCV) in the segment to and from the spinal cord was calculated as (D X2)/ (F-M-l). D was the distance from the ankle stimulus site to the spinal cord, measured as the surface distance to the T12 spinous process via the greater trochanter of the femur. M/F, MCV divided by FWCV, represented the ratio of conduction velocity of the distal portion to that of the entire length of the post-tibial nerve.
Statistical Analysis
Data are presented as mean ± SD. Results of the nerve conduction studies were evaluated by unpaired Students t test, and single correlations between variables were assessed by Pearson's coefficient of correlation. A level of P <0.05 was accepted as statistically significant.
RESULTS
There were no significant differences in age between the diabetic patients and control participants, but the group with non-diabetic poly neuropathy was younger than either the diabetic patients (P < 0.001) or the control participants (P < 0.01).
Nerve Conduction Studies
The MCV of post-tibial nerves and SCV of sural nerves in the diabetic patients were slower than those of the normal control participants (Table 1) . Although there was no significant difference between diabetic patients and normal control participants in FWCV of post-tibial nerves, the M/F ratio in the diabetic patients was significantly smaller than that of normal control participants. There was no significant difference in MCV of post-tibial nerves and SCV of sural nerves between the non-diabetic patients with neuropathy and normal control participants. The FWCV of the post-tibial nerves in the non-diabetic patients was slower than that of normal participants; the calculated M/F ratio was larger than that of normal control participants. Among the non-diabetic patients with peripheral neuropathy, the M/F ratio was also significantly larger (segmental de myelination, 1.05 ± 0.11, P < 0.001; alcoholic neuropathy, 1.032 ± 0.01, P < 0.001; axonal neuropathy, 1.01 ± 0.13, P < 0.05) than that of normal control participants. The FWCV was significantly slower (segmental de myelination, 38.7 ± 4.8 m/s, P < 0.001; alcoholic neuropathy, 41.0 ± 7.0 m/s, P < 0.01) than that of normal control participants. Correlation between age and nerve conduction variables (Table 2) The M/F ratio was not correlated with age in normal control participants, although there were significant negative correlations among age and motor, sensory, and F-wave conduction velocities. In the diabetic patients, however, conduction velocities and the M/F ratio were not correlated with age. The M/F ratio in the patients with non-diabetic poly neuropathy was also not correlated with age. The M/F ratio was not affected by sex and height of the participants.
Feasibility of Using the M/F Ratio in the Differential Diagnosis of Diabetic Neuropathy
We compared study groups for the incidence of abnormality in MCV, SCV, FWCV, or the M/F ratio to test the specificity of each parameter in the diagnosis of diabetic neuropathy. A value greater than the mean + 2 SD or less than mean -2 SD of the control value was considered abnormal. High incidences of abnormalities in MCV and SCV were present in the diabetic patients, whereas a high incidence of an abnormality in FWCV was present in the patients with non-diabetic neuropathy. A low incidence of an abnormality in SCV was detected in the non-diabetic patients with neuropathy. A striking contrast was evident when we compared the incidence of an M/F ratio greater than mean + 2 SD (high M/F ratio) and that of an M/F ratio less than mean -2 SD (low M/F ratio). About 20% of the patients with diabetic neuropathy had a low M/F ratio but none of these patients had a high M/F ratio. In contrast, about 48% of the nondiabetic patients with neuropathy had a high M/F ratio, whereas none of these patients had a low M/F ratio. 
DISCUSSION
The main advantage of F-wave methodology has been in the detection of peripheral neuropathies in which Fwaves may show clinically significant and measurable changes even before Conventional nerve conduction studies are informative. [2] This is because the slowing of nerve conduction is maximized by F waves travelling for long distances over the entire length of the nerve. Different patterns of F-wave abnormality have been demonstrated in patients with various peripheral Nerve disorders [2] , as well as in diabetic neuropathy [6, 7] . Although F-response latency was considered a sensitive indicator of peripheral neuropathy [8] , amplitude and duration in ulnar nerve F response were the other sensitive parameters for the detection of mild diabetic neuropathy in type 1 diabetes. [7] F-wave study added to conventional nerve conduction studies should provide more information that is useful in diagnosing the early stages of diabetic neuropathy. Another application of Fwave measurement is in the evaluation of proximal nerve lesions. [9] F-wave studies can provide useful information about patients who have lumbar or cervical root compression [10] or the carpal tunnel syndrome [9] . It would be useful to exclude complications like radiculopathy in patients with diabetes. While several useful F-wave parameters have been reported, the routine application of F-waves is mainly limited to latency measurement. Kimura et al. [3] suggested that the latency ratio of the proximal to the distal segment (F ratio) was reduced in diabetic patients. They concluded that motor conduction abnormalities in diabetic poly neuropathy were diffuse over the entire length of the nerve, but were more intense in the distal than in the proximal segment. In this study, according to authors, the M/F ratio as a new parameter that have some advantages over the parameters previously determined by conventional nerve conduction or F-wave studies. The M/F ratio is not affected by age, whereas MCV, SCV [4] , and F-wave latency [11] may be influenced by age. M/F ratio proved useful for the differential diagnosis of diabetic neuropathy. Subgroups of various pathological patterns of peripheral neuropathy, such as segmental demyelination, axonal neuropathy, SMON, and alcoholic neuropathy, can be differentiated from that of diabetic neuropathy on the basis of the M/F ratio. Although the incidence of an abnormal M/F ratio was relatively low, its assessment together with the SCV or FWCV provided a more specific diagnosis of diabetic neuropathy. The pathological changes in diabetic neuropathy are so complicated, that some studies have cited electrophysiological and pathological evidence of segmental demyelination as the primary lesion. [12] However, other studies have shown axonal damage to be the initiating event. [13] Because segmental demyelination and axonal damage coexist in patients with diabetic neuropathy [14] , nerve conduction studies, which primarily reflect the functional status of large myelinated nerve fibers, reveal various patterns. The F ratio and the M/F ratio have been used in an effort to clarify these patterns. Kimuras F ratio and our M/F ratio are similar. Use of the entire FWCV would increase sensitivity to longitudinal, heterogeneous, and subtle changes in the peripheral nerves, rather than to proximal-to-distal changes. Exactly why the M/F ratio should be able to discriminate diabetic neuropathy from non-diabetic neuropathy is unclear. Studies of additional patients with an analysis of the pathological changes, together with electrophysiological studies, are indicated. Our findings suggest that the M/F ratio is a useful parameter for the differential diagnosis of diabetic neuropathy.
